BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hewitt DB, Brown ZJ, Pawlik TM. Surgical management of intrahepatic cholangiocarcinoma. Expert Rev Anticancer Ther 2021;:1-12. [PMID: 34730474 DOI: 10.1080/14737140.2022.1999809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Mima K, Hayashi H, Yumoto S, Matsumoto T, Tsukamoto M, Miyata T, Nakagawa S, Nitta H, Baba H. Disability in perioperative activities of daily living is associated with worse survival outcomes following hepatic resection in patients with intrahepatic cholangiocarcinoma. Hepatol Res 2023;53:135-44. [PMID: 36305859 DOI: 10.1111/hepr.13849] [Reference Citation Analysis]
2 Guo K, Lou Y, Zheng S. Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma. Biomed Res Int 2023;2023:6638755. [PMID: 36704724 DOI: 10.1155/2023/6638755] [Reference Citation Analysis]
3 Vatankhah F, Salimi N, Khalaji A, Baradaran B. Immune checkpoints and their promising prospect in cholangiocarcinoma treatment in combination with other therapeutic approaches. Int Immunopharmacol 2023;114:109526. [PMID: 36481527 DOI: 10.1016/j.intimp.2022.109526] [Reference Citation Analysis]
4 Hu S, Xia C, Zou H, Ren W, Liu L, Wang L, Kang Q, He K, Wang T, Zhang X. HS6ST1 overexpressed in cancer-associated fibroblast and inhibited cholangiocarcinoma progression. Dig Liver Dis 2022:S1590-8658(22)00831-3. [PMID: 36586771 DOI: 10.1016/j.dld.2022.12.007] [Reference Citation Analysis]
5 Kupietzky A, Ariche A. Surgical Aspects of Intrahepatic Cholangiocarcinoma. Cancers (Basel) 2022;14. [PMID: 36551749 DOI: 10.3390/cancers14246265] [Reference Citation Analysis]
6 Kone LB, Bystrom PV, Maker AV. Robotic Surgery for Biliary Tract Cancer. Cancers (Basel) 2022;14:1046. [PMID: 35205792 DOI: 10.3390/cancers14041046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]